Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ: BOLT · Real-Time Price · USD
6.27
+2.08 (49.64%)
At close: Oct 23, 2026, 4:00 PM EDT
6.86
+0.59 (9.41%)
After-hours: Oct 23, 2026, 7:59 PM EDT
Bolt Biotherapeutics Market Cap
Bolt Biotherapeutics has a market cap or net worth of $12.08 million as of October 23, 2026. It is the 40,304th most valuable company in the world and the 5,493rd biggest in the United States. Its market cap has increased by 12.17% in one year.
Market Cap
12.08M
Enterprise Value
16.10M
1-Year Change
12.17%
Global Rank
Country Rank
#5,493 United States
Category
ChartMarket Cap Chart
Since the IPO on February 5, 2021, Bolt Biotherapeutics's market cap has decreased from $690.43M to $12.08M, a decrease of -98.25%. That is a compound annual growth rate of -50.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 12.08M | 15.08% |
| Dec 31, 2025 | 10.50M | -48.75% |
| Dec 31, 2024 | 20.48M | -51.84% |
| Dec 29, 2023 | 42.52M | -13.15% |
| Dec 30, 2022 | 48.96M | -73.20% |
| Dec 31, 2021 | 182.69M | -73.54% |
| Feb 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Daré Bioscience | 12.70M |
| SeaStar Medical Holding | 12.68M |
| Vyome Holdings | 12.56M |
| Tvardi Therapeutics | 12.54M |
| Cerenome | 12.45M |
| Pluri | 12.22M |
| AEON Biopharma | 11.97M |
| Lipocine | 11.87M |